AI Verdict
AAPL has stronger fundamentals based on our AI analysis.
GLUC vs AAPL Fundamental Comparison
| Metric | GLUC | AAPL |
|---|---|---|
| Revenue | $72,940.0 | $143.8B |
| Net Income | $39,018.0 | $42.1B |
| Net Margin | 53.5% | 29.3% |
| ROE | N/A | 47.7% |
| ROA | 148.1% | 11.1% |
| Current Ratio | 0.06x | 0.97x |
| Debt/Equity | N/A | 1.00x |
| EPS | N/A | $2.84 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GLUC vs AAPL: Frequently Asked Questions
Is GLUC or AAPL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AAPL has stronger fundamentals. GLUC is rated STRONG SELL (72% confidence) while AAPL is rated BUY (87% confidence). This is not investment advice.
How does GLUC compare to AAPL fundamentally?
Glucose Health, Inc. has ROE of N/A vs Apple Inc.'s 47.7%. Net margins are 53.5% vs 29.3% respectively.
Which stock pays higher dividends, GLUC or AAPL?
GLUC has a dividend yield of N/A or no dividend while AAPL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GLUC or AAPL for long term?
For long-term investing, consider that GLUC has STRONG SELL rating with 72% confidence, while AAPL has BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GLUC vs AAPL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GLUC vs AAPL, the AI consensus favors AAPL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.